Article Details
Retrieved on: 2024-01-27 22:37:28
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights Ironwood Pharmaceuticals' stock activity and institutional investor interest, particularly in their GI treatment product, linaclotide, indicating a significant stock market movement for this equity security.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here